Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Hair proteins have weak spots in their α-helical segments.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Electrolysis is effective for permanent hair removal, but technique is key to avoid scarring, and sometimes hormonal treatment is needed for women with hirsutism.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Minoxidil works better than nitroglycerin for treating impotence with fewer side effects.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

All three treatments reduce hirsutism, but spironolactone works best long-term.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.